Correlation Between Diamyd Medical and Metro AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and Metro AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and Metro AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and Metro AG, you can compare the effects of market volatilities on Diamyd Medical and Metro AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of Metro AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and Metro AG.

Diversification Opportunities for Diamyd Medical and Metro AG

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Diamyd and Metro is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and Metro AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metro AG and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with Metro AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metro AG has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and Metro AG go up and down completely randomly.

Pair Corralation between Diamyd Medical and Metro AG

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 2.47 times more return on investment than Metro AG. However, Diamyd Medical is 2.47 times more volatile than Metro AG. It trades about 0.31 of its potential returns per unit of risk. Metro AG is currently generating about -0.27 per unit of risk. If you would invest  99.00  in Diamyd Medical AB on September 23, 2024 and sell it today you would earn a total of  37.00  from holding Diamyd Medical AB or generate 37.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy77.27%
ValuesDaily Returns

Diamyd Medical AB  vs.  Metro AG

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.
Metro AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Metro AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Metro AG is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Diamyd Medical and Metro AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and Metro AG

The main advantage of trading using opposite Diamyd Medical and Metro AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, Metro AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metro AG will offset losses from the drop in Metro AG's long position.
The idea behind Diamyd Medical AB and Metro AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume